Your browser doesn't support javascript.
loading
A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402).
Yokoyama, Toshihide; Yoshioka, Hiroshige; Fujimoto, Daichi; Demura, Yoshiki; Hirano, Katsuya; Kawai, Takahiro; Kagami, Ryogo; Washio, Yasuyoshi; Ishida, Tadashi; Kogo, Mariko; Tomii, Keisuke; Okuno, Takehiro; Akai, Masaya; Hirabayashi, Masataka; Nishimura, Takashi; Nakahara, Yasuharu; Kim, Young Hak; Miyakoshi, Chisato; Yoshimura, Kenichi; Hirai, Toyohiro.
Afiliación
  • Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Yoshioka H; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan. Electronic address: hgyoshioka@gmail.com.
  • Fujimoto D; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Demura Y; Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
  • Hirano K; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Kawai T; Department of Respiratory Medicine, Kyoto-Katsura Hospital, Kyoto, Japan.
  • Kagami R; Department of Respiratory Medicine, Himeji Medical Center, Himeji, Japan.
  • Washio Y; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ishida T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Kogo M; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Okuno T; Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
  • Akai M; Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
  • Hirabayashi M; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Nishimura T; Department of Respiratory Medicine, Kyoto-Katsura Hospital, Kyoto, Japan.
  • Nakahara Y; Department of Respiratory Medicine, Himeji Medical Center, Himeji, Japan.
  • Kim YH; Department of Respiratory Medicine, Kyoto University Hospital, Kyoto, Japan.
  • Miyakoshi C; Clinical Research Center, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yoshimura K; Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan.
  • Hirai T; Department of Respiratory Medicine, Kyoto University Hospital, Kyoto, Japan.
Lung Cancer ; 135: 175-180, 2019 09.
Article en En | MEDLINE | ID: mdl-31446992
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Afatinib / Neoplasias Pulmonares / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Afatinib / Neoplasias Pulmonares / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón